Abbott India share news, announcements and annual reports
NSE: ABBOTINDIABSE: 500488Pharmaceuticals & BiotechnologyMid Cap
Abbott India Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 1966
Last close ₹25,635.00down ₹510.00 (1.95%)BSE ₹25,593.30
Share price at the NSE close on 30 Oct 2026. Previous close ₹26,145.00.
30 Oct: open ₹26,005.00, high ₹26,455.00, low ₹25,555.00
52-week range of traded prices to 30 Oct 2026
₹24,650.00Low, 23 Oct 2026₹30,655.00High, 25 Nov 2025
- Next results date: the board meets on 5 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹54,473 Cr183rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 33.74
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 11.41
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.56%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 35.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 39.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 8,62143.4% delivered
Abbott India board and management
72 filed, newest first. Page 2 of 2.
Jun 2020
22 Jun · Management
8 Jun · Management
Feb 2020
Oct 2019
Jun 2019
11 Jun · Management
Apr 2019
Mar 2019
Jun 2018
1 Jun · Management
Apr 2018
26 Apr · Management
Mar 2018
Aug 2017
8 Aug · Management
Jul 2017
18 Jul · Management
Sep 2016
Feb 2016
29 Feb · Management
1. Mr Rehan A. Khan has vide his letter dated February 29, 2016 tendered resignation as the Managing Director and Director of the Company ....
Oct 2015
30 Oct · Management
Mr. R A Shah, Non-Executive Director of the Company has been re-appointed as an Independent Director effective October 28, 2015 for a term upto March ....
Aug 2015
5 Aug · Management
Intimation received from Mr R A Shah and noted by the Board of Directors, Mr Shah ceased to be Independent Director effective July 31, 2015. ....
May 2015
27 May · Management
Ms. Nancy Berce has been appointed as an Additional Director of the Company to hold office upto the conclusion of the forthcoming Annual General Meeting.
Mar 2015
5 Mar · Management
Ms. Valentine Yien has resigned as Director of the Company effective February 28 2015. The resignation letter has been received by the Company on March 05, 2015.
Dec 2013
24 Dec · Management
Ms. Valentine Yien has been appointed as the Additional Director of the Company effective December 23, 2013.
Nov 2013
7 Nov · Management
Mr. Thomas Joseph Dee has resigned as Director of the Company effective September 30, 2013. The Board at its meeting held on November 07, 2013, ....
Mar 2012
15 Mar · Management
1. Mr. Vivek Mohan has been offered a global role in the Abbott Group as Senior Director - Global Integrated Health, Established Pharmaceuticals ....
Dec 2010
24 Dec · Management
Mr. Zahirali Lavji has resigned as director on the Board with effect from December 31, 2010.